Soleno Therapeutics Inc (NASDAQ:SLNO) currently has a daily average trading volume of 1.05M but it saw 1709881 shares traded in last market. With a market cap of 4.62B USD, the company’s current market price of $87.64 came rising about 2.48 while comparing to the previous closing price of $85.52. In past 52 weeks, the stock remained buoying in the range of price level as high as $90.32 and as low as $41.50. In the recent trading on the day, stock has struck highest price mark of $84.73 while lowest mark touched by it was $88.6.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the TD Cowen which initiated the stock as “Buy” in its note to investors issued on June 23, 2025, recommending a price target of $110 for it. Stifel issued its recommendations for the stock as it reiterated the price target for the stock is $74.
Over the week, SLNO’s stock price is moving 9.11% up while it is 12.14% when we observe its performance for the past one month. Year-to-date it is 74.55% up and over the past year, the stock is showing an upside performance of 94.97%.
Currently, Soleno Therapeutics Inc’s total number of outstanding shares is 48.53M. Company’s return on investment (ROI) stands at -69.69% and return on equity (ROE) at -105.54%. It has a 66.85 of forward P/E ratio. Stock’s beta reads -2.56. Stock has a price to book (P/B) ratio of 18.31. Its return on asset (ROA) is -81.42% on average.
